When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A ...

The 2020 Nobel Prize in Chemistry was awarded for the development of CRISPR/Cas9, a method also known as "gene scissors," ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

The model is built on CRISPR technology, a powerful gene editing tool used to edit genomes and develop therapies for genetic diseases. However, training to use this tool for designing experiments can ...

When brain development gets off to a bad start, the consequences are lifelong.   One example is a condition called SCN2A haploinsufficiency, in which children are born with just one functioning copy ...

When the genome-editing tool CRISPR is thought of as a potential medicine, the targets that first come to mind are diseases like sickle cell or other conditions caused by particular mutations. Use ...

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

In the new study, researchers used CRISPR gene editing to insert the ancient uricase ... There are existing gout therapies ...

CRISPR Therapeutics AG stock has surged nearly 90% since my Buy call in early May, reaching its highest value since February 2024. The rally builds on the historic approval of Casgevy, a gene editing ...